Zhejiang Jingxin Pharmaceutical (002020.SZ) is planning to go public in Hong Kong.
Jingxin Pharmaceutical (002020.SZ) announced that the company plans to issue overseas listed shares (H shares) and apply for listing on the main board of the Stock Exchange of Hong Kong in China.
Zhejiang Jingxin Pharmaceutical (002020.SZ) announced that the company plans to issue overseas listed shares (H shares) and apply for listing on the main board of the Hong Kong Stock Exchange.
Related Articles
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
